CME Group Inc. (NASDAQ:CME) will release its third-quarter earnings report before the opening bell on Wednesday, Oct. 21.
Analysts expect the Chicago, Illinois-based company to report quarterly earnings of $2.98 per share, up from $2.68 per share in the year-ago period. The consensus estimate for CME’s quarterly revenue is $1.71 billion. It reported $1.54 billion last year, according to Benzinga Pro.
On Oct. 8, CME Group reported that international average daily volume surged 22% to 9 million contracts in the third quarter.
CME Group shares gained 1.5% to close at $293.87 on Friday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- Morgan Stanley analyst Michael Cyprys maintained an Overweight rating and raised the price target from $330 to $337 on Oct. 9, 2026. This analyst has an accuracy rate of 67%.
- Barclays analyst Benjamin Budish maintained an Equal-Weight rating and increased the price target from $270 to $281 on Oct. 7, 2026. This analyst has an accuracy rate of 70%.
- UBS analyst Alex Kramm maintained a Neutral rating and boosted the price target from $260 to $270 on Oct. 5, 2026. This analyst has an accuracy rate of 69%.
- TD Cowen analyst Bill Katz maintained a Buy rating and raised the price target from $292 to $300 on Oct. 5, 2026. This analyst has an accuracy rate of 62%.
- Deutsche Bank analyst Brian Bedell downgraded the stock from Buy to Hold and cut the price target from $286 to $270 on Aug. 19, 2026. This analyst has an accuracy rate of 73%.
Considering buying CME stock? Here’s what analysts think:
Photo via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
